Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9,614,000
-
Total 13F shares
-
26,338,868
-
Share change
-
+4,804,702
-
Total reported value
-
$484,403,324
-
Price per share
-
$18.40
-
Number of holders
-
68
-
Value change
-
+$83,801,125
-
Number of buys
-
35
-
Number of sells
-
26
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q1 2021
As of 31 Mar 2021,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,338,868 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, VIKING GLOBAL INVESTORS LP, FRANKLIN RESOURCES INC, VR Adviser, LLC, Avidity Partners Management LP, CITADEL ADVISORS LLC, Logos Global Management LP, BlackRock Inc., and JANUS HENDERSON GROUP PLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.